Dr Jim D Bates, DO | |
1378 Pioneer Trl, Bullhead City, AZ 86429-1112 | |
(928) 234-4321 | |
(928) 404-2150 |
Full Name | Dr Jim D Bates |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1378 Pioneer Trl, Bullhead City, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275572992 | NPI | - | NPPES |
227571 | Medicaid | AZ | |
834640 | Other | AZ | BCBS |
330005009 | Other | AZ | MEDICARE RAILROAD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 1897 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jim D Bates, DO 2744 Silvercreek Rd, Bullhead City, AZ 86442-7913 Ph: (928) 704-7166 | Dr Jim D Bates, DO 1378 Pioneer Trl, Bullhead City, AZ 86429-1112 Ph: (928) 234-4321 |
News Archive
A paper published in the current issue of Psychotherapy and Psychosomatics, provides a careful analysis of network analysis, a new methodology for understanding psychiatric symptoms.
Working with mice, a multicenter team of researchers has found a new way to reduce the abnormal blood vessel growth and leakage in the eye that accompany some eye diseases. The finding could lead to the development of new drugs for wet macular degeneration and diabetic macular edema.
Illumina, Inc. today announced that its Board of Directors has approved a new stock repurchase program, authorizing the Company to repurchase in the aggregate up to $75 million of its outstanding common stock.
January 26, 2015) About 10 percent of young leukemia patients of East Asian ancestry inherit a gene variation that is associated with reduced tolerance of a drug that is indispensable for curing acute lymphoblastic leukemia (ALL), the most common childhood cancer.
"Much still needs to be done to get treatment to those who need it and to meet the UNAIDS-endorsed goal to achieve universal access by 2015, according to a new survey examining 25 HIV indicators assessing strategies, tools and policies to get the best HIV treatment to more people, sooner," the Center for Global Health Policy's "Science Speaks" blog reports.
› Verified 8 days ago